These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

426 related articles for article (PubMed ID: 33292652)

  • 1. N6-methyladenine modification in noncoding RNAs and its function in cancer.
    Yang X; Hu X; Liu J; Wang R; Zhang C; Han F; Chen Y; Ma D
    Biomark Res; 2020 Nov; 8(1):61. PubMed ID: 33292652
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The role of N6-methyladenosine-modified non-coding RNAs in the pathological process of human cancer.
    Luo L; Zhen Y; Peng D; Wei C; Zhang X; Liu X; Han L; Zhang Z
    Cell Death Discov; 2022 Jul; 8(1):325. PubMed ID: 35851061
    [TBL] [Abstract][Full Text] [Related]  

  • 3. N6-Methyladenosine-Sculpted Regulatory Landscape of Noncoding RNA.
    Zhang Z; Wei W; Wang H; Dong J
    Front Oncol; 2021; 11():743990. PubMed ID: 34722298
    [TBL] [Abstract][Full Text] [Related]  

  • 4. N6-methyladenosine (m6A) modification in osteosarcoma: expression, function and interaction with noncoding RNAs - an updated review.
    Zhang Y; Xu Y; Bao Y; Luo Y; Qiu G; He M; Lu J; Xu J; Chen B; Wang Y
    Epigenetics; 2023 Dec; 18(1):2260213. PubMed ID: 37766615
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The interplay between m6A RNA methylation and noncoding RNA in cancer.
    Ma S; Chen C; Ji X; Liu J; Zhou Q; Wang G; Yuan W; Kan Q; Sun Z
    J Hematol Oncol; 2019 Nov; 12(1):121. PubMed ID: 31757221
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Novel insights into the interaction between N6-methyladenosine methylation and noncoding RNAs in musculoskeletal disorders.
    Han J; Kong H; Wang X; Zhang XA
    Cell Prolif; 2022 Oct; 55(10):e13294. PubMed ID: 35735243
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Overview of the interplay between m6A methylation modification and non-coding RNA and their impact on tumor cells.
    Dou Z; Ma XT; Piao MN; Wang JP; Li JL
    Transl Cancer Res; 2024 Jun; 13(6):3106-3125. PubMed ID: 38988908
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Crosstalk between N6-methyladenosine (m6A) modification and noncoding RNA in tumor microenvironment.
    Wang D; Han Y; Peng L; Huang T; He X; Wang J; Ou C
    Int J Biol Sci; 2023; 19(7):2198-2219. PubMed ID: 37151887
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The roles of N6-methyladenosine and its target regulatory noncoding RNAs in tumors: classification, mechanisms, and potential therapeutic implications.
    Liu Z; Gao L; Cheng L; Lv G; Sun B; Wang G; Tang Q
    Exp Mol Med; 2023 Mar; 55(3):487-501. PubMed ID: 36854773
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Insights into N6-methyladenosine (m6A) modification of noncoding RNA in tumor microenvironment.
    Zhang Y; Zhan L; Li J; Jiang X; Yin L
    Aging (Albany NY); 2023 May; 15(9):3857-3889. PubMed ID: 37178254
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The interplay between m6A modification and non-coding RNA in cancer stemness modulation: mechanisms, signaling pathways, and clinical implications.
    Qin S; Mao Y; Wang H; Duan Y; Zhao L
    Int J Biol Sci; 2021; 17(11):2718-2736. PubMed ID: 34345203
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The relationship between the network of non-coding RNAs-molecular targets and N6-methyladenosine modification in tumors of urinary system.
    Li R; Zhu C; Wang Y; Wang X; Wang Y; Wang J; Wang K
    Cell Death Dis; 2024 Apr; 15(4):275. PubMed ID: 38632251
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Unraveling the cross-talk between N6-methyladenosine modification and non-coding RNAs in breast cancer: Mechanisms and clinical implications.
    Liu X; Xie X; Sui C; Liu X; Song M; Luo Q; Zhan P; Feng J; Liu J
    Int J Cancer; 2024 Jun; 154(11):1877-1889. PubMed ID: 38429857
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Circular RNAs, Noncoding RNAs, and N6-methyladenosine Involved in the Development of MAFLD.
    Nakashima M; Suga N; Ikeda Y; Yoshikawa S; Matsuda S
    Noncoding RNA; 2024 Feb; 10(1):. PubMed ID: 38392966
    [TBL] [Abstract][Full Text] [Related]  

  • 15. N6-methyladenosine RNA modification and its interaction with regulatory non-coding RNAs in colorectal cancer.
    Ge Y; Liu T; Wang C; Zhang Y; Xu S; Ren Y; Feng Y; Yin L; Pu Y; Liang G
    RNA Biol; 2021 Nov; 18(sup2):551-561. PubMed ID: 34674600
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Novel Insights Into the Role of N6-Methyladenosine RNA Modification in Bone Pathophysiology.
    Chen J; Tian Y; Zhang Q; Ren D; Zhang Q; Yan X; Wang L; He Z; Zhang W; Zhang T; Yuan X
    Stem Cells Dev; 2021 Jan; 30(1):17-28. PubMed ID: 33231507
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Non-Coding RNA m6A Modification in Cancer: Mechanisms and Therapeutic Targets.
    Chen DH; Zhang JG; Wu CX; Li Q
    Front Cell Dev Biol; 2021; 9():778582. PubMed ID: 35004679
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Crosstalk between m6A and coding/non-coding RNA in cancer and detection methods of m6A modification residues.
    Meng Q; Schatten H; Zhou Q; Chen J
    Aging (Albany NY); 2023 Jul; 15(13):6577-6619. PubMed ID: 37437245
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Main N6-Methyladenosine Readers: YTH Family Proteins in Cancers.
    Dai XY; Shi L; Li Z; Yang HY; Wei JF; Ding Q
    Front Oncol; 2021; 11():635329. PubMed ID: 33928028
    [TBL] [Abstract][Full Text] [Related]  

  • 20. New understandings of the genetic regulatory relationship between non-coding RNAs and m
    Liu S; Xiang D
    Front Genet; 2023; 14():1270983. PubMed ID: 38125749
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.